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Abstract
Background: Acute undifferentiated febrile illness (AUFI) is caused by a multitude of diverse pathogens, with
significant morbidity and mortality in the developing world. The objective of this review was to characterise the
diversity and relative importance of common infectious aetiologies of AUFI in South and Southeast Asia.
Methods: We conducted a comprehensive literature review to identify common aetiologies of AUFI in Asian
countries. Four medical and life sciences databases including PubMed, Medline, Embase and Cochrane Central, and
Google Scholar were searched for articles published from January 1998 to March 2019.
Results: Forty-three studies met the inclusion criteria. Among AUFI cases, viral aetiologies at 18.5% (14888) were
more common than bacterial aetiologies (12.9% [10384]). From 80,554 cases, dengue fever was the most common
aetiology (11.8%, 9511), followed by leptospirosis (4.4%, 3549), typhoid (4.0%, 3258), scrub typhus (4.0%, 3243) and
influenza other than H1N1 (3.1%, 2514). In both adults and children: dengue fever was the leading cause of AUFI
with 16.6% (1928) and 18.7% (1281) of the total cases. In admitted patients, dengue fever was the main cause of
AUFI at 16.4% (2377), however leptospirosis at 13.9% (2090) was the main cause of AUFI for outpatients. In South
Asia, dengue fever was the main cause of AUFI, causing 12.0% (6821) of cases, whereas in Southeast Asia,
leptospirosis was the main diagnosis, causing 12.1% (2861) of cases.
Conclusions: In this study the most common causes of AUFI were viral, followed by bacterial and protozoal
(malaria) infections. Dengue was the commonest virus that caused AUFI while leptospirosis and typhoid were
important bacterial infectious causes. Therefore, it is imperative to maintain a sound epidemiological knowledge of
AUFI so that evidence-based diagnostic criteria and treatment guidelines can be developed.
Keywords: Acute undifferentiated febrile illness, Asia, Infection
Background
During the past 20 years, there has been a dramatic
emergence and re-emergence of viruses, bacteria and
parasitic infections, including novel pathogens as well as
those previously believed to be under control. Many of
these pathogens cause acute undifferentiated febrile ill-
ness (AUFI, or acute febrile illness, AFI). The common
causes of AUFI include malaria, dengue fever, enteric
fever, leptospirosis, rickettsiosis, hantavirus and Japanese
encephalitis [1–3]. AUFI contributes to substantial mor-
bidity and death among children and adults worldwide
[4, 5]. Many preventable deaths occur because of incor-
rect or delayed diagnosis, largely due to limited access to
medical care and laboratory diagnostic facilities in the
developing countries [6–9]. The majority of patients
present with non-specific symptoms such as low-grade
fever, general malaise, headache, arthralgia, myalgia, and
rash; and usually without a focal point of infection. The
symptoms and differential diagnoses of these diseases
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are similar, making accurate clinical diagnosis difficult
without laboratory confirmation [10–12].
In recent decades, dengue has rapidly emerged as a
major cause of AUFI in tropical Asia particularly in the
World Health Organization (WHO) Southeast Asia
(SEA) region [13, 14]. However, many other infectious
diseases can cause a dengue-like illness with thrombo-
cytopaenia, including scrub typhus, chikungunya, infec-
tious mononucleosis, malaria, typhoid fever,
leptospirosis and acute human immuno-deficiency virus
conversion disease [15]. Presumptive diagnosis and
reporting of AUFI with thrombocytopaenia as dengue
infection would lead to over-reporting of this infection
and under-reporting of other illnesses.
Evidence-based decision-making in health requires the
availability of sound data, but good quality information
on the occurrence of infectious diseases is unavailable
for most countries in Asia [16]. The provision of accur-
ate epidemiological data for common pathogens will en-
able identification of changing patterns of disease
aetiology and burden, allowing informed priority setting,
and optimal allocation of resources to key areas. Under-
standing the common causes of AUFI in resource-poor
settings in tropical and subtropical countries will help
improve case management. In areas where there is lim-
ited access to laboratory diagnosis, the local epidemi-
ology of AUFI and validated clinical predictors may help
guide presumptive diagnosis and therapeutic interven-
tions. Such information is also crucial for developing ap-
propriate diagnostic tests and guidelines, and informing
resource mobilization and public health interventions.
Therefore, the objective of this review was to synthesise
information on the diversity and relative importance of
common infectious aetiologies of AUFI in recent history
in South and Southeast Asia given it is a melting point
of tropical infectious diseases and a hotspot for disease
emergence [14, 17, 18].
Methods
Search strategy and inclusion criteria
A systematic literature review was undertaken in four
medical and life sciences databases including PubMed,
Medline, Embase and Cochrane Central, and Google
Scholar search machine was also used. Publications from
the last 21 years (January 1998–March 2019) were in-
cluded because laboratory tests and diseases patterns
have changed during recent decades in many parts of
South and Southeast Asia. Articles were obtained elec-
tronically or in paper form. The search words included:
i) aetiology OR etiology OR causes AND ii) acute febrile
illnesses OR iii) undifferentiated fevers AND Asia OR
Thailand OR Malaysia OR Singapore OR India OR Sri
Lanka OR Nepal OR Bangladesh OR Pakistan OR
Vietnam OR Laos OR Cambodia OR Indonesia OR
Myanmar OR Timor-Leste OR Bhutan OR Maldives OR
Philippines. The review included articles published in
English only.
We did not limit our search by study design or patient
age. Data were derived from studies on inpatients as well
as outpatients with AUFI with no focus of infections
identified after taking a detailed history and clinical
examination. Inclusion criteria were: a) primary articles,
published in peer review journals on AFI/AUFI in South
Asia (Bhutan, Bangladesh, India, Nepal, and Sri Lanka)
and Southeast Asia (Cambodia, Laos, Indonesia,
Malaysia, Myanmar, Philippines, Singapore, Thailand,
and Vietnam); b) published reports between January
1998 and March 2019 (to improve the reliability of la-
boratory confirmation and to reflect the distribution of
more recent disease patterns) and c) published in Eng-
lish. Exclusion criteria included: a) studies carried out in
other parts of Asia (Middle East and central Asia); b)
studies conducted before 1998; c) articles such as
preliminary reports, and case reports; d) editorials,
opinions, review articles, vaccine and drug trials; and e)
case reports and fever associated with a travel history
(Additional file 1: Table S1). Titles and abstracts were
screened for compliance with the inclusion criteria and
then full papers were reviewed.
Data analysis
The selection of citations by title and abstract was car-
ried out independently by two researchers (KW and
SKK). The selected studies underwent a full-text review
for all potentially relevant studies. Data from the 43 in-
cluded studies were independently extracted in a spread-
sheet by KW and SKK. Information from each paper
was extracted and entered in to a Microsoft Excel (2010
version) spread sheet. Descriptive data included study lo-
cation, study period, type of patients (inpatients/ outpa-
tients/ both), age range and duration of fever.
Quantitative data recorded included number of patients,
pathogens isolated, and common presenting signs and
symptoms. Paediatric data were defined as those that in-
cluded patients younger than 16 years. Studies with non-
segregated data for adults and children were analysed
separately. Data for pathogens isolated in each study
were compiled and analysed in aggregate to compare
common aetiologies of AUFI. The proportion of fevers
confirmed through laboratory diagnosis in each study
were recorded as the main outcome measure.
Risk of bias assessment
The risk of bias (ROB) of the included studies was
assessed using a modified checklist used previously
[19]. The studies were assessed using eight questions
with a possible maximum count of eight safe-guards
(Additional file 1: Table S2), with three questions to
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assess external validity, and five questions for internal val-
idity. We did not assess the ROB for the sampling meth-
odology of populations with acute febrile illness, as these
were defined populations presenting to a health facility
with acute infection and no population-based sampling
was used to capture these populations.
Results
Identification of studies
Using the key words in the search, 2064 articles were
identified from four life science data base (PubMed,
Medline, Web of Science, Embase) and Google Scholar.
The titles and abstracts of all studies identified by the
search strategy were screened for their relevance to this
review and 1640 records that were not relevant for fever
with infectious aetiologies were discarded. Four hundred
fifteen (424) reports were screened further and from
those records, 366 were excluded after reviewing the ab-
stracts as they did not meet the inclusion criteria. All
remaining 58 full text articles were reviewed using
pre-determined criteria. A full-text review led to the
exclusion of a further 15 papers, including five studies
with potentially relevant data that were excluded as
three of them were carried out in 1991, one study in
1994 and the other study from 1994 to 1999. The
remaining 43 studies were from 11 countries in South
and Southeast Asia, including a multicentre study,
were then analysed (Fig. 1).
Characteristics of included studies
Twenty-eight studies were from South Asia, of which 20
were from India. In the South East Asia, there were 15
studies and Thailand reported the highest number of
studies in the region with nine studies (Fig. 2). There
was one multi-centre study carried out in Indonesia,
Malaysia, Philippines, Thailand and Vietnam. Most were
prospective studies (n = 31) and six studies were retro-
spective; three were cross-sectional; one cohort study
and two active fever surveillance (Table 1).
Definition of fever duration in the acute febrile ill-
nesses described in these studies varied widely, from 1
to 30 days. Of the 43 included studies, 19 included dur-
ation of fever of < 14 days [2, 11, 20–36], seven studies
had fever duration of < 21 days [7, 12, 37–41], three
studies reported fever with the duration of < 30 days [1,
42, 43], 13 studies did not define any specific duration
[44–56] and one study recruited patients with acute
fever of more than 4 days [57]. Similarly, the
temperature threshold used to define fever varied
from 37.5–38.5°Celsius. Sixteen studies included adult
(> 16 years) patients [1, 12, 21, 22, 32, 36–38, 40, 45,
47, 49–52, 55], eight studies included children (< 16
years) [7, 11, 25, 27, 39, 41, 42, 54] and 19 studies in-
cluded patients of all ages [2, 20, 23, 24, 26, 28–31,
33–35, 43, 44, 46, 48, 53, 56, 57]. The number of pa-
tients involved in each study varied from 50 to 38,
635. Data on a total of 80,554 patients were included
Fig. 1 Study selection
Wangdi et al. BMC Infectious Diseases          (2019) 19:577 Page 3 of 17
in the analysis of which 14.4% (11706) were adults,
8.5% (7840) were children and 77.1% (62068) were
not specified either as adults or children and 39 cases
could not be assigned to any age groups [35]. Among
adults, mean age varied from 27 to 39.5 years and
among children from 2 to 9.5 years. There were 19,
030 males, 14,625 females (with a male to female ra-
tio of 1.3:1), and gender was not reported for 46,899
patients.
Twenty-five studies included patients admitted to
hospital [1, 7, 12, 21–23, 27, 32–35, 37, 38, 40–45,
47, 48, 50, 52, 55, 57] making up 18.7% (14420) of
the total study sample (80554). Six studies included
patients attending outpatients department correspond-
ing to 18.7% (15075) of study sample [2, 11, 20, 24,
28, 39]. Twelve studies included patients attending
outpatient departments (OPD) and those admitted to
hospital wards representing 63.4% (51059) of total study
sample [25, 26, 29–31, 36, 46, 49, 51, 53, 54, 56]. Common
presenting symptoms were given in 24 studies, corre-
sponding to 30,397 patients. Amongst these 23 studies,
the most common presenting symptom was headache
39.7% (12072) followed by cough 29.7% (9035) and chills
20.5% (6241) (Additional file 1: Table S3).
In all studies excepting one [34], diagnoses were made
according to interpretation of antibody titres. Pathogen-
specific IgM titres were determined by using IgM-
capture enzyme-linked immunosorbent assay (ELISA)
kits, which are commercially available. Molecular testing
(using polymerase chain reaction [PCR] was carried out
in 16 studies [24–27, 29, 30, 35, 38–40, 42, 49, 50, 54–
56]. Serological diagnoses were confirmed by blood cul-
tures in 16 studies out of 43 [2, 20–22, 24, 26, 32, 37, 40,
42, 43, 45, 47, 48, 50, 51]. Microscopy was used for the
diagnosis in 15 studies [20–22, 24, 26, 32, 37, 43, 44, 46,
47, 49–51, 55]. Nucleotide sequencing was done in two
studies [29, 35] (Fig. 3 and Additional file 1: Table S4).
Aetiology of AUFI was identified in 37.7% (30333) of
patients: with viral aetiologies in 18.5% (14888) being
the most common, followed by bacterial and protozoal
aetiologies with 12.9% (10384), and 2.8% (2281) respect-
ively. The underlying diagnosis could not be ascertained
in 64.6% of patients (52003). Twenty studies reported
378 deaths in patients with AUFI [1, 2, 20–22, 25–27,
Fig. 2 Summary of the studies by countries and regions. The size of the circles indicates the relative number of patients and light colour is the
proportion of study subjects with unidentified aetiology. Countries with blue colour are in South East Asia and green colour are in South Asia
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31, 34, 36, 38, 41–45, 48–50]. Co-infections were re-
ported in 1.2% (981) of total cases, the most common
co-infections with two organisms 0.9% (740).
Aetiology of AUFI by age group
In adults, the commonest infection was from bacterial
causes at 26.1% (3037), followed by viral aetiologies
18.6% (2169). The most common aetiologies of AUFI
in adults were dengue fever 16.6% (1928), scrub ty-
phus 10.7% (1244), malaria 9.8% (1139), leptospirosis
6.3% (732) and typhoid 6.0% (696). On the other
hand, viral infection was the commonest cause of
fever among children corresponding to 23.8% (1625)
of the diagnosed cases, followed by bacterial aetiol-
ogies and malaria (corresponding to 6.4% (435) and
0.8% (57) of diagnosed cases, respectively). Dengue
fever, chikungunya, and typhoid were the commonest
cause of AUFI in children representing 18.7% (1281),
1.7% (114), and 1.6% (107) respectively. In the un-
specified age group (UAG), dengue fever was the
commonest cause of AUFI with 10.2% (6302) of total
cases; leptospirosis was the second commonest cause
with 4.4% (2729); typhoid and malaria contributed
4.0% (2455) and 1.7% (1085) of total cases (Table 2
and Fig. 4).
Aetiology of AUFI by site of patient recruitment
Among the 14,450 hospitalised patients, bacterial in-
fection 23.1% (3340) was the leading cause of fever.
However, the most common aetiology of AUFI was
dengue fever 16.4% (2377), followed by scrub typhus
10.0% (1449), malaria 6.9% (990), and leptospirosis
6.8% (989). A total of 7053 representing 48.8% did
not have a known diagnosis. Even though viral infec-
tions (36.7%, 5536) were the main cause for fever in
outpatients, leptospirosis 13.9% (2090) was the com-
monest cause of AUFI followed by influenza other
than HINI 13.8% (2077), dengue 8.5% (1277), and
hepatitis E 6.9% (1038). Dengue was the commonest
infection in patients recruited from both IP and OPD
11.5% (5857), followed by typhoid 3.8% (1940), mal-
aria 2.4% (1234), scrub typhus 2.3% (1165), and lepto-
spirosis 0.9% (470) respectively (Table 3 and Fig. 4).
Aetiology of AUFI by region
In both the regions, viral aetiologies were the leading
cause of AUFI with 33.0% (7828) and 12.4% (7060)
for SEA and South Asia, respectively. However, there
was significant differences in the burden of AUFI
when stratified by individual aetiologies. In South
Asia, the commonest cause of fever was dengue fever
12.0% (6821) followed by typhoid 4.3% (2449), and
malaria 3.0% (1722). While Leptospirosis was the
leading infection 12.1% (2861) in SEA followed by
dengue fever 11.4% (2690), influenza other than
H1N1 10.6% (2511), and hepatitis E 4.4% (1038)
(Table 4 and Fig. 4).
Fig. 3 Summary of different diagnostic methods. (MAT- microscopic agglutination test; ELISA- enzyme-linked immunosorbent assay; PCR-
polymerase chain reaction)
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Table 2 Common aetiologies of AUFI stratified by age
Organism Adults (n; %) Children (n; %) UAG (n; %) Total (n; %)
Viral aetiologies 2169 (18.6) 1625 (23.8) 11,094 (17.9) 14,888 (18.5)
Dengue 1928 (16.6) 1281 (18.7) 6302 (10.2) 9511 (11.8)
JE*** 5 (0.0) 71 (1.0) 233 (0.4) 309 (0.4)
Influenza** 180 (1.5) 48 (0.7) 2286 (3.7) 2514 (3.1)
H1N1 5 (0.0) 1 (0.0) 513 (0.8) 519 (0.6)
Chikungunya 15 (0.1) 114 (1.7) 326 (0.5) 455 (0.6)
Hepatitis A 8 (0.1) 7 (0.1) 58 (0.1) 73 (0.1)
Hepatitis B 5 (0.0) 0 (0.0) 267 (0.4) 272 (0.3)
Hepatitis E 2 (0.0) 0 (0.0) 1038 (1.7) 1040 (1.3)
Flavi virus 0 (0.0) 65 (1.0) 0 (0.0) 65 (0.1)
Para influenza 1 0 (0.0) 10 (0.1) 0 (0.0) 10 (0.0)
Para influenza 3 0 (0.0) 28 (0.4) 0 (0.0) 28 (0.0)
Hanta virus 2 (0.0) 0 (0.0) 71 (0.1) 73 (0.1)
HIV 19 (0.2) 0 (0.0) 0 (0.0) 19 (0.0)
Bacterial aetiologies 3037 (26.1) 435 (6.4) 6912 (11.1) 10,384 (12.9)
Leptospirosis 732 (6.3) 88 (1.3) 2729 (4.4) 3549 (4.4)
Typhoid 696 (6.0) 107 (1.6) 2455 (4.0) 3258 (4.0)
Paratyphoid 57 (0.5) 0 (0.0) 0 (0.0) 57 (0.1)
Rickettsiosis diseases 1449 (12.5) 140 (2.0) 1654 (2.7) 3243 (4.0)
Scrub typhus 1244 (10.7) 103 (1.5) 1512 (2.4) 2859 (3.5)
Murine typhus 171 (1.5) 0 (0.0) 101 (0.2) 272 (0.3)
Spotted fever 34 (0.3) 37 (0.5) 41 (0.1) 112 (0.1)
Q fever 7 (0.1) 0 (0.0) 0 (0.0) 7 (0.0)
E coli 11 (0.1) 21 (0.3) 26 (0.0) 58 (0.1)
Burkholderia pseudomallei 3 (0.0) 14 (0.2) 6 (0.0) 23 (0.0)
Tuberculosis 29 (0.2) 6 (0.1) 8 (0.0) 43 (0.1)
Klebsiella pneumoniae 1 (0.0) 0 (0.0) 2 (0.0) 3 (0.0)
Haemophilus influenza 0 (0.0) 0 (0.0) 9 (0.0) 9 (0.0)
Staph aureus 0 (0.0) 37 (0.5) 12 (0.0) 49 (0.1)
Strep pneumoniae 51 (0.4) 18 (0.3) 6 (0.0) 75 (0.1)
Strep Gr A 0 (0.0) 0 (0.0) 2 (0.0) 2 (0.0)
Strep Gr C 0 (0.0) 0 (0.0) 1 (0.0) 1 (0.0)
Neisseria meningitis 1 (0.0) 4 (0.1) 2 (0.0) 7 (0.0)
Protozoa 1139 (9.8) 57 (0.8) 1085 (1.7) 2281 (2.8)
Malaria 1139 (9.8) 57 (0.8) 1085 (1.7) 2281 (2.8)
Fungal aetiologies 0 (0.0) 0 (0.0) 3 (0.0) 3 (0.0)
Yeast non-Cryptococci 0 (0.0) 0 (0.0) 2 (0.0) 2 (0.0)
Cryptococcus neoformans 0 (0.0) 0 (0.0) 1 (0.0) 1 (0.0)
Co infections 251 (2.2) 30 (0.4) 700 (1.1) 981 (1.2)
Co infection* 226 (1.9) 30 (0.4) 484 (0.8) 740 (0.9)
Co infection† 25 (0.2) 0 (0.0) 210 (0.3) 235 (0.3)
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Case fatalities
A total of 378 deaths were reported across 20 studies
corresponding to a case fatality rate (CFR) of 0.5%.
There were 114 deaths in the SEA region with a CFR
of 0.5%. In South Asia, the CFR was 0.5% with 264
deaths. More than half (172) of the deaths were in
patents whose age was unknown, with a case fatality
of 0.3%, followed by children with 81 deaths (CFR of
1.2%), and adults with 112 deaths (CFR 1.3%). Most
of the deaths occurred in hospitalised patients 270
(CFR 1.9%) followed by both inpatients and outpa-
tients 78 (CFR 0.2%).
Risk of bias
The quality of the studies including types of study,
randomization and other characteristics was assessed
through eight safeguards against bias as outlined in
the Additional file 1: Table S2. The ranges of score
were 4–8. The most common safeguard missing was
study’s target population. Only 15 studies recruited
patients of all ages presenting with AUFI. The other
studies restricted study population either to children
or adults. All studies had study instrument that had
validity and reliability (Additional file 1: Table S5).
Discussion
The findings of this review illustrate that in tropical and
subtropical South and Southeast Asian countries, the
most common causes of AUFI were viruses, followed by
bacteria and malaria. Generally, dengue fever was the
commonest cause followed by leptospirosis and typhoid.
Consistent with our findings, the decline in malaria
cases in Asia and Africa has resulted in a relative in-
crease in non-malarial AUFIs in these continents [58].
Non-malarial fever was responsible for 20–50% of all fe-
vers in Asia and Africa in children over 5 years of age
and adults [59]. While dengue was mostly frequently re-
ported febrile illness in Latin America [60].
Leptospirosis was the leading cause of AUFI in the
Southeast region similar to other reported studies from
that region [61–65], in agricultural workers [66, 67] and
mostly in males [68]. The ability of all countries in the
Table 2 Common aetiologies of AUFI stratified by age (Continued)
Organism Adults (n; %) Children (n; %) UAG (n; %) Total (n; %)
Co infection‡ 0 (0.0) 0 (0.0) 6 (0.0) 6 (0.0)
Unknown/others 5036 (43.3) 4693 (68.6) 42,274 (68.1) 52,003 (64.6)
Deaths 125 (33.1) 81 (21.4) 172 (45.5) 378 (100.0)
UAG Unknown age group, ***JE Japanese B Encephalitis; 39 cases in the manuscript could not be assigned to any age group; **influenza other than H1N1; *co-
infection with two organisms; †co-infection with three organisms; ‡co-infection with more than three organisms
The bold face shows the cumulative number of the stratified groups
Fig. 4 Summary graph of main categories of AUFI across age group, region and site of patient recruitment in Asia. (UAG- unknown age group,
IP-inpatient; OP-outpatient; SEA-Southeast Asia, SA- South Asia)
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Table 3 Aetiology of AUFI by site of patient recruitment
Organism IP (n; %) OP (n; %) OP+IP (n; %) Total (n; %)
Viral aetiologies 2721 (18.8) 5536 (36.7) 6631 (13.0) 14,888 (18.5)
Dengue 2377 (16.4) 1277 (8.5) 5857 (11.5) 9511 (11.8)
JE*** 77 (0.5) 7 (0.0) 225 (0.4) 309 (0.4)
Influenza** 86 (0.6) 2077 (13.8) 351 (0.7) 2514 (3.1)
HINI 6 (0.0) 513 (3.4) 0 (0.0) 519 (0.6)
Chikungunya 54 (0.4) 224 (1.5) 177 (0.3) 455 (0.6)
Hepatitis A 0 (0.0) 62 (0.4) 11 (0.0) 73 (0.1)
Hepatitis B 4 (0.0) 267 (1.8) 1 (0.0) 272 (0.3)
Hepatitis E 2 (0.0) 1038 (6.9) 0 (0.0) 1040 (1.3)
Flavi virus 65 (0.4) 0 (0.0) 0 (0.0) 65 (0.1)
Para influenza 1 10 (0.1) 0 (0.0) 0 (0.0) 10 (0.0)
Para influenza 3 28 (0.2) 0 (0.0) 0 (0.0) 28 (0.0)
Hanta virus 1 (0.0) 71 (0.5) 1 (0.0) 73 (0.1)
HIV 11 (0.1) 0 (0.0) 8 (0.0) 19 (0.0)
Bacterial aetiologies 3340 (23.1) 3383 (22.4) 3662 (7.2) 10,385 (12.9)
Leptospirosis 989 (6.8) 2090 (13.9) 470 (0.9) 3549 (4.4)
Typhoid 406 (2.8) 912 (6.0) 1940 (3.8) 3258 (4.0)
Paratyphoid 57 (0.4) 0 (0.0) 0 (0.0) 57 (0.1)
Rickettsial diseases 1670 (11.6) 341 (2.3) 1232 (2.4) 3243 (4.0)
Scrub typhus 1449 (10.0) 245 (1.6) 1165 (2.3) 2859 (3.5)
Murine typhus 178 (1.2) 65 (0.4) 29 (0.1) 272 (0.3)
Spotted fever 43 (0.3) 31 (0.2) 38 (0.1) 112 (0.1)
Q fever 7 (0.0) 0 (0.0) 0 (0.0) 7 (0.0)
E coli 29 (0.2) 25 (0.2) 4 (0.0) 58 (0.1)
Burkholderia pseudomallei 17 (0.1) 3 (0.0) 3 (0.0) 23 (0.0)
Tuberculosis 36 (0.2) 0 (0.0) 7 (0.0) 43 (0.1)
Klebsiella pneumonia 2 (0.0) 0 (0.0) 2 (0.0) 4 (0.0)
Haemophilus influenza 9 (0.1) 0 (0.0) 0 (0.0) 9 (0.0)
Staph aureus 39 (0.3) 8 (0.1) 2 (0.0) 49 (0.1)
Strep pneumonia 73 (0.5) 2 (0.0) 0 (0.0) 75 (0.1)
Strep Gr A 1 (0.0) 0 (0.0) 1 (0.0) 2 (0.0)
Strep Gr C 0 (0.0) 0 (0.0) 1 (0.0) 1 (0.0)
Neisseria meningitis 5 (0.0) 2 (0.0) 0 (0.0) 7 (0.0)
Protozoa 990 (6.9) 57 (0.4) 1234 (2.4) 2281 (2.8)
Malaria 990 (6.9) 57 (0.4) 1234 (2.4) 2281 (2.8)
Fungal aetiologies 3 (0.0) 0 (0.0) 0 (0.0) 3 (0.0)
Yeast non-Cryptococci 2 (0.0) 0 (0.0) 0 (0.0) 2 (0.0)
Cryptococcus neoformans 1 (0.0) 0 (0.0) 0 (0.0) 1 (0.0)
Co infections 343 (2.4) 176 (1.2) 496 (1.0) 1015 (1.3)
Co infection* 331 (2.3) 169 (1.1) 270 (0.5) 770 (1.0)
Co infection† 12 (0.1) 7 (0.0) 220 (0.4) 239 (0.3)
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region to accurately report and monitor leptospirosis
hinges strongly on their respective capacity to provide
accurate and reliable laboratory diagnosis, and robust
reporting and surveillance systems [69, 70]. While the
microscopic agglutination test (MAT) is considered to
be the gold standard serological test [71], there are
limitations to the test including a need for live
cultures of Leptospira of different serogroups, cross-
reactions between serogroups and serovars, poor
sensitivity in the first week of illness, and persistence
of high titres for many years after an infection.
Conversely, treatment with antibiotics can blunt the
immune response in leptospirosis, reducing the num-
ber of cases detectable by serology [72]. Hence, the
number of leptospirosis patients reported in this re-
view could be under or overestimated.
Dengue was the commonest cause of AUFI in South
Asia contrary to Southeast Asia. It is generally a
childhood disease and our results are consistent with
that trend because it was the commonest cause of
AUFI among children [73–75]. In the past, dengue
cases were mostly hospitalized irrespective of the se-
verity of the disease. However, with the new admis-
sion criteria which includes clinical, laboratory, and
dengue haemorrhage fever (DHF) predictive parame-
ters [76], only severe cases of dengue: DHF and den-
gue shock syndrome (DSS) are admitted. The
admission criteria were not clear in our study since
most of the cases were from both OPD and IPD.
This review confirms that influenza is also an import-
ant cause of AUFI in the region, being the fourth com-
monest cause. Persistence of influenza virus especially in
Southeast Asia is thought to be mediated by domestic
ducks and large live poultry markets acting as a virus
reservoir [77, 78]. Seasonal influenza is a highly trans-
missible, abrupt, and usually a self-limiting febrile infec-
tion of the respiratory tract and the majority of patients
would present to outpatient departments [79, 80]. In
many countries, the disease burden from influenza is
underestimated because many cases are undiagnosed.
Typhoid fever was also identified as one of the major
causes of AUFI. Previous reports have indicated that
children are most at risk of developing typhoid fever
[81]. The disease remains an important public health
problem in developing countries. Similarly, rickettsial
diseases including scrub typhus (Orientia tsutsugamushi)
and murine typhus (Rickettsia typhi) were responsible
for a small fraction of AUFI in this review. However, it is
important to note that rickettsial diseases are an import-
ant cause of febrile illness worldwide but are often un-
diagnosed, sometimes leading to life-threatening
conditions [82–85]. Given rickettsial infections are treat-
able causes of AUFI, greater recognition of scrub typhus
and murine typhus is important to increase the index of
suspicion amongst the physicians so that cases are not
missed.
Protozoal infection particularly malaria was respon-
sible for 3.7% of all AUFI cases. This figure is likely to
have been an underestimate because four studies ex-
cluded malaria patients in their analysis as their inclu-
sion criteria were non-malarial patients. Of the 11
member countries in the WHO SEA Region, 10 are en-
demic for malaria. Six countries (Bhutan, Democratic
People’s Republic of Korea, Indonesia, Nepal, Sri Lanka,
and Thailand) are aiming for malaria elimination as a
longer-term goal [86], and Sri Lanka has already elimi-
nated malaria [87].
We found that 1.0% of AUFIs were associated with co-
infections, the majority being in inpatients. Patients not
responding to treatment for a particular infection or
those in whom the presentation was atypical or severe
should be suspected of harbouring a second infectious
agent. The possibility of co-infections of leptospirosis
with hepatitis E virus (HEV) [88] has been described as
water is the vehicle of transmission for both pathogens.
The under-diagnosis of mixed infections is very likely
due to the overlapping clinical spectrum [89]. The rela-
tively high morbidity and mortality in mixed infections
underscores the need for greater awareness of the possi-
bility of mixed infections as well as the need for optimal
use of microbiological laboratory services to reach a spe-
cific diagnosis [88].
Causes of fever remained unknown in more than half
of patients with AUFI in this review. Similar findings
have been reported in other studies, including a review
of AUFI in South Asian countries [90]. A lack of an
established diagnosis could be partly due to the fact that
laboratory confirmations were not done in many studies
of acute self-limiting viral infections. In addition, com-
mercial serological rapid diagnostic tests used are semi-
Table 3 Aetiology of AUFI by site of patient recruitment (Continued)
Organism IP (n; %) OP (n; %) OP+IP (n; %) Total (n; %)
Co infection‡ 0 (0.0) 0 (0.0) 6 (0.0) 6 (0.0)
Unknown 7053 (48.8) 5923 (39.3) 39,036 (76.5) 52,012 (64.5)
Deaths 270 (71.4) 30 (7.9) 78 (20.6) 378 (100.0)
IP Inpatients, OP Outpatients; ***JE- Japanese B Encephalitis, HAV Hepatitis A virus; HBV Hepatitis E virus, HEV Hepatitis E virus,
**Influenza other than H1N1; *co-infection with two organisms; †co-infection with three organisms; ‡co-infection with more than three organisms
The bold face shows the cumulative number of the stratified groups
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Table 4 Aetiology by region (Southeast Asia and South Asia)
Organism SEA (n; %) South Asia (n; %) Total (n; %)
Viral aetiologies 7828 (33.0) 7060 (12.4) 14,888 (18.5)
Dengue 2690 (11.4) 6821 (12.0) 9511 (11.8)
JE*** 309 (1.3) 0 (0.0) 309 (0.4)
Influenza** 2511 (10.6) 3 (0.0) 2514 (3.1)
HINI 514 (2.2) 5 (0.0) 519 (0.6)
Chikungunya 256 (1.1) 199 (0.3) 455 (0.6)
Hepatitis A 62 (0.3) 11 (0.0) 73 (0.1)
Hepatitis B 267 (1.1) 5 (0.0) 272 (0.3)
Hepatitis E 1038 (4.4) 2 (0.0) 1040 (1.3)
Flavi virus 65 (0.3) 0 (0.0) 65 (0.1)
Para influenza 1 10 (0.0) 0 (0.0) 10 (0.0)
Para influenza 3 28 (0.1) 0 (0.0) 28 (0.0)
Hanta virus 71 (0.3) 2 (0.0) 73 (0.1)
HIV 7 (0.0) 12 (0.0) 19 (0.0)
Bacterial aetiologies 4873 (20.6) 5512 (9.7) 10,385 (12.9)
Leptospirosis 2861 (12.1) 688 (1.2) 3549 (4.4)
Typhoid 809 (3.4) 2449 (4.3) 3258 (4.0)
Paratyphoid 0 (0.0) 57 (0.1) 57 (0.1)
Rickettsial diseases 1009 (4.3) 2234 (3.9) 3243 (4.0)
Scrub typhus 764 (3.2) 2095 (3.7) 2859 (3.5)
Murine typhus 146 (0.6) 126 (0.2) 272 (0.3)
Spotted fever 99 (0.4) 13 (0.0) 112 (0.1)
Q fever 7 (0.0) 0 (0.0) 7 (0.0)
E coli 49 (0.2) 9 (0.0) 58 (0.1)
Burkholderia pseudomallei 23 (0.1) 0 (0.0) 23 (0.0)
Tuberculosis 21 (0.1) 22 (0.0) 43 (0.1)
Klebsiella pneumoniae 3 (0.0) 1 (0.0) 4 (0.0)
Haemophilus influenza 9 (0.0) 0 (0.0) 9 (0.0)
Staph aureus 49 (0.2) 0 (0.0) 49 (0.1)
Strep pneumoniae 24 (0.1) 51 (0.1) 75 (0.1)
Strep Gr A 2 (0.0) 0 (0.0) 2 (0.0)
Strep Gr C 1 (0.0) 0 (0.0) 1 (0.0)
Neisseria meningitides 6 (0.0) 1 (0.0) 7 (0.0)
Protozoa 559 (2.4) 1722 (3.0) 2281 (2.8)
Malaria 559 (2.4) 1722 (3.0) 2281 (2.8)
Fungal aetiologies 3 (0.0) 0 (0.0) 3 (0.0)
Yeast non Cryptococci 2 (0.0) 0 (0.0) 2 (0.0)
Cryptococcus neoformans 1 (0.0) 0 (0.0) 1 (0.0)
Co infections 815 (3.4) 196 (0.3) 1011 (1.3)
Co infection* 592 (2.5) 178 (0.3) 770 (1.0)
Co infection† 217 (0.9) 18 (0.0) 235 (0.3)
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quantitative ELISAs that detect antibodies and are not
conclusive of the present or past infection [91, 92]. For
some pathogens, definitive diagnosis requires demon-
stration of a serial rise in antibody titres over a specific
time period. Noncompliance of patients to report for re-
peat serological tests following improvement of the ill-
ness remains a major drawback in serology-based
diagnostics [10, 93]. Moreover, ELISAs have poor speci-
fication and cross reactions are common [94]. Antigen-
based or PCR-based diagnostics have been increasingly
introduced to overcome these problems. However, their
availability and affordability in resource-poor countries
are limited, and the fact that they are not freely available
in most government-run health institutions means that
accessibility to such tests is limited to those in the pri-
vate sector who can afford to pay from their own pocket
[93].
This review has several limitations. Interpretation of
data in this study should take into consideration the het-
erogeneity of the reviewed studies including study de-
sign, patient sampling and diagnostic testing. In
addition, many of these studies were descriptive studies.
Furthermore, there is no reliable way to judge the quality
of heterogeneous descriptive studies included in this re-
view. Some articles failed to report duration of fever and
definition of AUFI varied widely between the studies.
Aetiologies of AUFI of less than one-week duration
would likely differ from those of a minimum of three
weeks. Therefore, adherence to a common case defin-
ition between studies is important to make comparisons
more reliable. Seasonal variation of diseases such as in-
fluenza, changes in disease patterns due to economic de-
velopment, urbanization, environmental changes and
changes in population densities during the last 15 years
could have affected observed aetiologies and disease pat-
terns. In addition, data from some countries including
Bhutan and Timor-Leste were not available and results
were also dominated by studies from India and Thailand.
Since English is not the primary language in most of
these countries, restricting the studies included in this
review to studies published in English may have affected
the findings.
Algorithms for the management of fevers at the com-
munity level as well as for inpatients have been
developed by WHO [59]. A lack of knowledge of the
geographical heterogeneity in AUFI aetiology prevents
local adaptation of generic protocols, and thus precludes
better targeting of drugs and implementation of early, ef-
fective management [95]. Therefore, it is necessary that
data on pathogen presence collected incidentally in vari-
ous studies and data collected by surveillance mecha-
nisms be analysed systematically and mapped to provide
information on the distribution and prevalence of infec-
tious aetiologies of AFIs. Clinical algorithms could then
be adapted, greatly improving targeting of treatment.
Strengthening of notification systems (including sentinel
systems) and sharing of data between clinical research
communities will be important to construct more com-
prehensive information on geographically specific aetiol-
ogies of AUFI.
Conclusion
In this study the most common causes of AUFI were
viral, followed by bacterial and protozoal (malaria) infec-
tions. Dengue was the commonest virus that caused
AUFI while leptospirosis and typhoid were important
bacterial infectious causes. The challenges of unidenti-
fied causes of AUFI can be partly overcome by roll-out
of affordable serological tests. It is imperative that data
on pathogen presence collected incidentally in various
studies and data collected by surveillance systems be
analysed systematically and mapped to provide informa-
tion on the distribution and prevalence of infectious ae-
tiologies of AFIs for improving treatment and
prevention programmes.
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